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What are the novel findings of this work?
In women with a twin pregnancy, we identified gestational
age at delivery to be a strong prognostic factor for the
composite outcome of perinatal mortality and severe
neonatal morbidity, an association that was dependent
upon the planned mode of delivery.
What are the clinical implications of this work?
Women with a twin pregnancy and the first twin in
cephalic presentation should be counseled that planned
vaginal delivery, compared with planned Cesarean
delivery, seems to have a favorable effect on perinatal
outcome from 32 to 37 weeks’ gestation, while, from
around 37 weeks onwards, Cesarean delivery might be
safer for both babies; however, the absolute risks are very
low.
ABSTRACT
Objective To evaluate whether there is a differential bene-
fit of planned Cesarean delivery (CD) over planned vaginal
delivery (VD) in women with a twin pregnancy and the
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first twin in cephalic presentation, depending on pre-
specified baseline maternal and pregnancy characteristics,
and/or gestational age (GA) at delivery.
Methods This was a secondary analysis of the Twin
Birth Study, which included 2804 women with a twin
pregnancy and the first twin (Twin A) in cephalic
presentation between 32 + 0 and 38 + 6 weeks’ gestation
at 106 centers in 25 countries. Women were assigned
randomly to either planned CD or planned VD. The
main outcome measure was composite adverse perinatal
outcome, defined as the occurrence of perinatal mortality
or serious neonatal morbidity in at least one twin. The
baseline maternal and pregnancy characteristics (markers)
considered were maternal age, parity, history of CD, use
of antenatal corticosteroids, estimated fetal weight (EFW)
of Twin A, EFW of Twin B, > 25% difference in EFW
between the twins, presentation of Twin B, chorionicity
on ultrasound, method of conception, complications
of pregnancy, ruptured membranes at randomization
and GA at randomization. Separate logistic regression
models were developed for each marker in order to
model composite adverse perinatal outcome as a function
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of the specific marker, planned delivery mode and
the interaction between these two terms. In addition,
multivariable logistic regression analysis with backward
variable elimination was performed separately in each
arm of the trial. The association between planned mode
of delivery and composite adverse perinatal outcome,
according to GA at delivery, was assessed using logistic
regression analysis.
Results Of the 2804 women initially randomized, 1391
were included in each study arm. None of the studied
baseline markers was associated with a differential
benefit of planned CD over planned VD in the rate of
composite adverse perinatal outcome. GA at delivery was
associated differentially with composite adverse perinatal
outcome in the treatment arms (P for interaction < 0.001).
Among pregnancies delivered at 32 + 0 to 36 + 6 weeks,
there was a trend towards a lower rate of composite
adverse perinatal outcome in those in the planned-VD
group compared with those in planned-CD group (29
(2.2%) vs 48 (3.6%) cases; odds ratio (OR) 0.62
(95% CI, 0.37–1.03)). In pregnancies delivered at or
after 37 + 0 weeks, planned VD was associated with a
significantly higher rate of composite adverse perinatal
outcome, as compared with planned CD (23 (1.5%) vs
10 (0.7%) cases; OR, 2.25 (95% CI, 1.06–4.77)).
Conclusion The perinatal outcome of twin pregnancies
with the first twin in cephalic presentation may differ
depending on GA at delivery and planned mode of
delivery. At 32–37 weeks, planned VD seems to be
favorable, while, from around 37 weeks onwards, planned
CD might be safer. The absolute risks of adverse perinatal
outcomes at term are low and must be weighed against
the increased maternal risks associated with planned
CD. © 2019 The Authors. Ultrasound in Obstetrics &
Gynecology published by John Wiley & Sons Ltd on
behalf of International Society of Ultrasound in Obstetrics
and Gynecology.
INTRODUCTION
Among the many challenges in the management of
women with twin pregnancy, mode of delivery is the
last decision to be made before birth. In order to answer
the question of whether delivery should be performed by
planned Cesarean delivery (CD) or by planned vaginal
delivery (VD), the Twin Birth Study (TBS) randomized
2804 women with a twin pregnancy and the first
twin presenting in cephalic position between 32 + 0 and
38 + 6 weeks’ gestation. The study showed that planned
CD, in comparison with planned VD, did not influence the
risk of perinatal mortality and morbidity (2.2% vs 1.9%;
odds ratio (OR), 1.16 (95% CI, 0.77–1.74); P = 0.49)1.
While the results of the TBS were reassuring, women
were included over a wide gestational-age (GA) range. The
impact of GA at delivery on perinatal outcome is much
stronger at early GAs of 32 to 33 weeks than at beyond
37 weeks. The relatively high prevalence of perinatal
mortality and morbidity at early GAs, in combination
with the increased rate of preterm birth in women with
a twin pregnancy, may mask the actual effect of mode of
delivery at term2–4.
The TBS incorporated a subgroup analysis for GA
at randomization (32 + 0 to 33 + 6 weeks, 34 + 0 to
36 + 6 weeks and 37 + 0 to 38 + 6 weeks), and found
no statistically significant association between GA at
randomization and planned mode of delivery. However,
delivery often occurred weeks after randomization. The
subgroup of women randomized after 37 weeks seemed
to benefit from planned CD in terms of composite
adverse perinatal outcome (seven events in 500 fetuses
(1.4%) in the planned-VD group compared with two
events in 477 fetuses (0.4%) in the planned-CD group;
OR = 3.3)1.
The aims of this re-analysis of the TBS data were
two-fold. First, we aimed to investigate whether baseline
maternal and pregnancy characteristics can be used to
guide the decision between planned CD and planned VD.
Second, we aimed to evaluate the impact of GA at delivery
on the association between planned delivery method and
the primary outcome of the trial, which was a composite
of perinatal mortality and severe neonatal morbidity.
METHODS
Study design and participants
This was a secondary analysis of data collected in
the TBS (trial registration number ISRCTN74420086,
NCT00187369; protocol http://sites.utoronto.ca/miru/
tbs/Protocol_march_2005.pdf), which was a multicen-
ter open-label randomized controlled trial conducted
between 2003 and 2011 that had recruited 2804 women
with a twin pregnancy from 106 participating centers in
25 countries. The background, methods, baseline charac-
teristics of the participating women and the results have
been reported previously1. In short, women were eligi-
ble for the study if they had a twin pregnancy between
32 + 0 and 38 + 6 weeks’ gestation, the first twin (Twin A)
was in cephalic presentation and both fetuses were alive
with an estimated weight between 1500 g and 4000 g,
confirmed by ultrasound within 7 days before randomiza-
tion. Women with a pregnancy as early as 32 weeks were
enrolled, because many women with a twin pregnancy
wish to begin planning the method of delivery at this
stage and because many twin births are preterm.
After providing informed consent, women were
assigned randomly to planned CD or planned VD, using a
computerized randomization program with stratification
according to parity (0 vs ≥ 1) and GA. The trial profile
is illustrated in Figure 1. Participants with an indication
for delivery underwent either elective CD (for those in
the planned-CD group) or labor induction (for those in
the planned-VD group). Delivery was planned between
37 + 5 weeks and 38 + 6 weeks, as evidence at the time
suggested that perinatal outcome is optimal during this
GA window. The primary outcome of the TBS was
a composite of perinatal mortality or serious neonatal
© 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 582–591.
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Women randomized in TBS
(n = 2804)
Women with data on
both infants included
in analysis (n = 1391)
Included in TBS
(n = 1393 women)
(n = 2786 infants)
Women randomized to
planned CD (n = 1398) 
Women randomized to
planned VD (n = 1406)
Lost to follow-up
(n = 5 women)
(n = 10 infants) 
Included in TBS
(n = 1393 women)
(n = 2785 infants)
Women with data on
both infants included
in analysis (n = 1391) 
Composite adverse perinatal outcome
in one or more infants (n = 50)
Twin A only (n = 15), Twin B only
 (n = 33), both twins (n = 2)
 Outcome:
 Stillbirth (n = 8)
 Neonatal death (n = 8)
 Intrapartum death (n = 1)
 Death, unknown timing (n = 0)
 Serious neonatal morbidity (n = 35)
Composite adverse perinatal outcome
in one or more infants (n = 49)
Twin A only (n = 11), Twin B only
 (n = 27), both twins (n = 11)
 Outcome:
 Stillbirth (n = 11)
 Neonatal death (n = 11)
 Intrapartum death (n = 0)
 Death, unknown timing (n = 2)
 Serious neonatal morbidity (n = 36)
Lost to follow-up
(n = 1 woman)
(n = 2 infants)
Lost to follow-up
(n = 13 women)
(n = 26 infants)
Lost to follow-up
(n = 1 woman)
(n = 4 infants)
Figure 1 Flowchart summarizing randomization of women with twin pregnancy in Twin Birth Study (TBS) to planned Cesarean delivery
(CD) or planned vaginal delivery (VD).
morbidity. Serious neonatal morbidity was defined as one
or more of the following: birth trauma; 5-min Apgar
score < 4; abnormal level of consciousness; seizures on at
least two occasions before 72 h of age; need for assisted
ventilation with the use of an endotracheal tube, inserted
within 72 h after birth and remaining in place for at least
24 h; septicemia or meningitis within 72 h after birth;
necrotizing enterocolitis; bronchopulmonary dysplasia;
Grade-III or -IV intraventricular hemorrhage; or cystic
periventricular leukomalacia1.
The research ethics committee at each participating
center approved the study, and the Research Ethics Board
at the Sunnybrook Health Sciences Centre approved all
secondary analyses. For the purpose of this analysis, we
chose to use the binary outcome of composite adverse
perinatal outcome, defined as the occurrence of perinatal
mortality or serious neonatal morbidity in at least one
twin. At the time at which the trial was conducted, there
was no core outcome set for multiple pregnancy.
We selected a set of 13 baseline maternal and pregnancy
characteristics (markers) that have been suggested as prog-
nostic factors for outcome after planned CD or planned
VD. These were maternal age, parity, history of CD,
use of antenatal corticosteroids, estimated fetal weight
(EFW) of Twin A, EFW of Twin B, > 25% difference in
EFW between the twins (Twin B > Twin A), presentation
of Twin B (cephalic vs non-cephalic), chorionicity on
ultrasound, method of conception, complications of
pregnancy (presence of at least one of the following
complications: pre-eclampsia, other hypertensive dis-
orders, chorioamnionitis, placental abruption, placenta
previa, antepartum hemorrhage, diabetes or other
serious maternal or obstetrical complication), ruptured
membranes at randomization and GA at randomization.
In the original study, it was calculated that a sample size
of 2800 pregnancies would be needed in order to detect
a reduction from 4% to 2% in the risk of the composite
primary outcome of fetal or neonatal death or serious
neonatal morbidity with a policy of planned CD, with
80% power and a two-sided type-I error rate of 0.05,
allowing for a 10% rate of crossover between groups.
We estimated a power of about 76% for investigating
the effect of the interaction between GA at delivery and
management on composite adverse perinatal outcome,
which is a realistic and acceptable estimate for a subgroup
analysis (Appendix S1).
Statistical analysis
To evaluate if the decision regarding the planned mode of
delivery can potentially be guided by the selected markers,
we developed a series of logistic regression models,
each including one of the abovementioned markers, a
management indicator (planned VD vs planned CD) and a
© 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 582–591.
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marker-by-management interaction term. The dependent
variable of the models was composite adverse perinatal
outcome for either of the twins. Furthermore, we used
multivariable logistic regression modeling including all
markers, using a stepwise backward elimination approach
(with Akaike information criterion) twice (once in the
planned-CD group and once in the planned-VD group), in
order to investigate whether we could identify a subgroup
of women whose predicted risk of composite adverse
perinatal outcome would be lower following planned CD
than it would be following planned VD.
We developed a logistic regression model to evaluate
the association between GA at delivery of Twin A (as
a continuous variable) and the outcome of the planned
delivery method. The model predicts the occurrence of
composite adverse perinatal outcome as a function of GA
at delivery, planned mode of delivery and the interaction
between these two terms. For all values of GA at delivery,
we calculated the risk of composite adverse perinatal
outcome separately for planned VD and planned CD and
calculated the risk difference; CIs for the risk differences
were calculated using bootstrapping.
We also compared composite adverse perinatal out-
come between the planned-VD and planned-CD groups
in the subgroup delivered at 32 + 0 to 36 + 6 weeks and
in the subgroup delivered at or after 37 + 0 weeks. ORs
with 95% CIs for the association between planned VD, as
compared with planned CD, and composite adverse peri-
natal outcome and its components were calculated using
a logistic regression model for any fetus and separately
for Twin A and Twin B.
All analysis in this study was exploratory and performed
based on an intention-to-treat principle. We used R for
Windows (Version 3.0.1; R Foundation for Statistical
Computing, Vienna, Austria).
RESULTS
Of 1393 women who were planned to deliver by CD,
1252 (89.9%) eventually delivered both twins by CD
and 140 (10.1%) delivered one or both twins vaginally
(11 (0.7%) women had a combined delivery); 92 (6.6%)
women delivered vaginally at the woman’s request, and
data were missing for one woman. Of 1393 women who
were planned to deliver vaginally, 783 (56.2%) delivered
both twins vaginally, 144 (10.3%) delivered by Cesarean
section at the woman’s request and the remaining 466
(33.5%) delivered at least one of the twins by Cesarean
section because of maternal or fetal indications; 59 women
(4.2%) had a combined delivery. The reasons for CD in
both groups are summarized in Table S1.
Of 1391 women with information on both fetuses
allocated to planned CD, 49 (3.5%) experienced
composite adverse perinatal outcome; 11 (0.8%) cases
occurred in Twin A only, 27 (1.9%) in Twin B only and 11
(0.8%) in both twins. Among the 1391 women allocated
to planned VD with information on both fetuses, 50
(3.6%) experienced composite adverse perinatal outcome;
15 (1.1%) cases occurred in Twin A only, 33 (2.4%) in
Twin B only and 2 (0.1%) in both twins (Figure 1). This
resulted in a relative risk (RR) of composite adverse
perinatal outcome in the planned-VD vs planned-CD
group of 0.98 (95% CI, 0.66–1.44).
Baseline characteristics in guiding management
Table 1 summarizes the distribution of the 13 investigated
markers in each arm of the trial. Generally, the
distribution of the studied markers was similar between
the trial arms. The association between each marker and
composite adverse perinatal outcome following planned
VD or planned CD is also presented in Table 1. In both
the planned-VD and planned-CD trial arms, higher GA at
randomization was associated significantly with a lower
risk of composite adverse perinatal outcome (OR, 0.84
(95% CI, 0.71–0.98) and OR, 0.73 (95% CI, 0.61–0.87),
respectively) (Figure S1).
We did not observe a statistically significant interaction
with planned mode of delivery for any of the studied
markers (Table 1) and they therefore did not show any
potential to aid in the decision between planned CD and
planned VD in the studied population of women.
Multivariable logistic regression analysis of the
association between the studied markers and composite
adverse perinatal outcome was performed with stepwise
backward variable selection. In the planned-VD group,
none of the variables remained in the model. In the
planned-CD group, the only variable that remained in
the model was GA at randomization. The full models
are summarized in Table S2. We could not identify any
combination of baseline characteristics that would aid
in the identification of women who were more likely to
benefit from planned CD over planned VD.
Association between GA at delivery and risk of
composite adverse perinatal outcome
Median GA at randomization was 34.9 weeks (interquar-
tile range (IQR) 33.3–36.4 weeks) and median GA at
delivery was 37.0 weeks (IQR, 35.9–37.9 weeks). Median
time from enrollment to delivery was 1.3 weeks (IQR,
0.3–3.0 weeks). In the study group overall, GA at deliv-
ery was associated significantly with the risk of com-
posite adverse perinatal outcome (OR, 0.67 (95% CI,
0.60–0.76)); in other words, for each additional week of
gestation, the risk of composite adverse perinatal outcome
decreased by 33%.
While women allocated to planned CD delivered
on average only 0.1 week earlier than did those
allocated to planned VD (mean ± SD, 36.7 ± 1.5 weeks
vs 36.8 ± 1.5 weeks), the association between GA at
delivery and composite adverse perinatal outcome differed
between the trial arms (Table S3). Figure 2a shows the
probability of composite adverse perinatal outcome as a
function of GA at delivery. In women allocated to planned
CD, the risk of composite adverse perinatal outcome
was higher at earlier GAs (32–36 weeks) at delivery.
The difference became smaller with more advanced GA,
© 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 582–591.
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Table 1 Baseline characteristics of 2786 twin pregnancies in Twin Birth Study and association with composite adverse perinatal outcome,
according to randomization to planned vaginal delivery or planned Cesarean delivery
Planned vaginal delivery
(n = 1393 women and 2786 infants)
Planned Cesarean delivery
(n = 1393 women 2785 infants)
Characteristic n/N (%) OR (95% CI) n/N (%) OR (95% CI)
P for
interaction*
Maternal age 1.00 (0.96–1.05) 1.01 (0.96–1.06) 0.948†
< 25 years 12/365 (3.3) 16/371 (4.3)
25–29 years 14/396 (3.5) 11/390 (2.8)
30–34 years 14/357 (3.9) 9/366 (2.5)
35–39 years 9/222 (4.1) 10/216 (4.6)
> 39 years 1/53 (1.9) 3/50 (6.0)
Parity 0.108
Nulliparous 18/537 (3.4) Reference 22/536 (4.1) Reference
Parous 32/856 (3.7) 1.12 (0.63–2.06) 27/857 (3.2) 0.76 (0.43–1.36)
Previous Cesarean delivery 0.62
Yes 4/97 (4.1) 1.17 (0.35–2.95) 6/100 (6.0) 1.85 (0.69–4.15)
No 46/1296 (3.5) Reference 43/1293 (3.3) Reference
Gestational age at randomization 0.84 (0.71–0.98) 0.73 (0.61–0.87) 0.095†
32 + 0 to 33 + 6 weeks 25/478 (5.2) 24/475 (5.1)
34 + 0 to 36 + 6 weeks 18/665 (2.7) 23/679 (3.4)
37 + 0 to 38 + 6 weeks 7/250 (2.8) 2/239 (0.8)
Method of conception 0.273
Spontaneous 38/1170 (3.2) Reference 42/1156 (3.6) Reference
Assisted reproduction 12/223 (5.4) 1.69 (0.83–3.20) 7/237 (3.0) 0.81 (0.33–1.71)
EFW Twin A 0.999 (0.998–1.000) 0.999 (0.998–1.00) 0.618†
< 2000 g 21/409 (5.1) 20/440 (4.5)
2000–2499 g 22/578 (3.8) 21/563 (3.7)
2500–2999 g 7/351 (2.0) 7/323 (2.2)
≥ 3000 g 0/53 (0.0) 1/65 (1.5)
EFW Twin B 0.999 (0.998–0.999) 0.999 (0.998–1.00) 0.922†
< 2000 g 24/412 (5.8) 22/419 (5.3)
2000–2499 g 21/602 (3.5) 19/607 (3.1)
2500–2999 g 5/313 (1.6) 7/311 (2.3)
≥ 3000 g 0/65 (0.0) 1/54 (1.9)
Difference in EFW > 25%, Twin B > Twin A 0.982
Yes 0/15 (0.0) — 1/10 (10.0) 3.08 (0.17–16.87)
No 50/1376 (3.6) Reference 48/1380 (3.5) Reference
Presentation of Twin B 0.292
Cephalic 23/783 (2.9) Reference 28/792 (3.5) Reference
Non-cephalic 27/610 (4.4) 1.53 (0.87–2.72) 21/601 (3.5) 0.99 (0.55–1.75)
Chorionicity on ultrasound 0.194
Dichorionic 42/970 (4.3) 2.06 (0.98–5.06) 32/961 (3.3) 1.01 (0.52–2.12)
Monochorionic 7/326 (2.1) Reference 11/334 (3.3) Reference
Antenatal corticosteroids used 0.735
Yes 23/452 (5.1) 1.81 (1.02–3.19) 24/452 (5.3) 2.06 (1.16–3.65)
No 27/941 (2.9) Reference 25/941 (2.7) Reference
Pregnancy complications 0.182
None 47/1289 (3.6) Reference 39/1253 (3.1) Reference
≥ 1 3/104 (2.9) 0.79 (0.19–2.21) 10/140 (7.1) 2.39 (1.11–4.72)
Membranes ruptured at randomization 0.589
Yes 3/76 (3.9) 1.11 (0.26–3.11) 5/83 (6.0) 1.84 (0.62–4.36)
No 47/1313 (3.6) Reference 44/1307 (3.4) Reference
Gestational age at delivery 0.68 (0.40–1.20) 0.19 (0.10–0.38) < 0.001
32 + 0 to 36 + 6 weeks 29/1292 (2.2) 48/1338 (3.6)
37 + 0 to 38 + 6 weeks 23/1490 (1.5) 10/1444 (0.7)
*P for interaction obtained using logistic regression analysis. †Odds ratios (OR) calculated using generalized estimation equation method,
which takes into account correlation between twins. When number of events in one cell is zero, stable OR cannot be calculated. EFW,
estimated fetal weight.
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Figure 2 (a) Risk of composite adverse perinatal outcome in twin pregnancies randomized to planned Cesarean delivery (CD) ( ) and
those randomized to planned vaginal delivery (VD) ( ), according to gestational age (GA). (b) Difference (with 95% CI) in model-based
estimated risks of composite adverse perinatal outcome (of one or both twins) between planned-CD and planned-VD groups, according to
GA at delivery. Values above 0 represent better outcome in planned-VD group, and those below zero represent better outcome in
planned-CD group.
and the lines for the two management options cross at
36 weeks. After 36 weeks, planned CD is associated with
a lower risk of composite adverse perinatal outcome. A
risk difference plot showed that the benefit from planned
VD is smaller when delivery is between 32 and 35.5 weeks
(Figure 2b). From 37 weeks onwards, the upper limit of
the 95% CI of the risk difference line crosses zero.
We classified the study groups into two subgroups
according to a GA at delivery of 32 + 0 to 36 + 6 weeks or
at or after 37 + 0 weeks. In Table 2, the rate of composite
adverse perinatal outcome and its components are shown
according to planned mode of delivery and GA at delivery.
The association between GA at delivery and composite
adverse perinatal outcome is presented separately for
Twin A and Twin B in Figure S2. With increasing GA at
delivery, the risk of composite adverse perinatal outcome
in both Twin A and Twin B was lower in the planned-CD
group. In the planned-VD group, the risk of composite
adverse perinatal outcome in Twin A differed only slightly
according to GA at delivery, whereas the risk of composite
adverse perinatal outcome in Twin B differed according to
GA between 33 and 35 weeks, was stable between 35 and
37 + 5 weeks, and varied again between 38 and 39 weeks.
There were 2630 twins delivered at 32 + 0 to
36 + 6 weeks (1292 in the planned-VD group, 1338 in
the planned-CD group). Of these fetuses, 29 (2.2%)
experienced composite adverse perinatal outcome in the
planned-VD group compared with 48 (3.6%) in the
planned-CD group (OR, 0.62 (95% CI, 0.37–1.03)).
No significant differences were found in any of the
individual components of composite adverse perinatal
outcome between the two planned modes of delivery.
There were 2934 twins born at or after 37 weeks
(1444 in the planned-CD group, 1490 in the planned-VD
group). Of these fetuses, 23 (1.5%) in the planned-VD
group experienced composite adverse perinatal outcome
compared with 10 (0.7%) in the group randomized
to planned CD (OR, 2.25 (95% CI, 1.06–4.77)). No
significant differences were observed in any of the
individual components of composite adverse perinatal
outcome between the two planned modes of delivery.
DISCUSSION
In this study, we identified GA at birth as a strong
prognostic factor for perinatal outcome, depending on
the planned mode of delivery. In pregnancies delivered
before 37 weeks, a trend towards a lower rate of composite
adverse perinatal outcome in those randomized to planned
VD was noted, while, from around 37 weeks onwards,
fewer cases of composite adverse perinatal outcome were
noted in pregnancies randomized to planned CD. The
effect was more pronounced with increasing GA.
In June 2017, the French JUMODA trial, which was
a prospective cohort study in 5915 women with a
twin pregnancy after 32 weeks and the first twin in
cephalic position, was published. The JUMODA trial
found a higher rate of adverse neonatal events in twins
born at 32–37 weeks after planned CD compared with
after planned VD (32 + 0 to 34 + 6 weeks: propensity
score matching OR, 1.72 (95% CI, 1.09–2.70); 35 + 0
to 36 + 6 weeks: propensity score matching OR, 2.52
(95% CI, 1.05–6.04)). These results are remarkably
similar to our findings5. Retrospective studies on the
effect of GA on neonatal outcomes related to the planned
mode of delivery for women with twin pregnancy have
reported similar results; before 36–37 weeks, the optimal
mode of delivery for twins is planned VD and, beyond
term, planned CD may result in better outcome3,6–9.
In our analysis, it was impossible to detect the exact
GA at which planned CD leads to better perinatal
outcome, as compared with planned VD. In previous
retrospective studies, this point was found to be from
36 weeks onwards3,6,9,10 while, in the JUMODA study,
this was from 37 weeks onwards5.
It is unlikely that a randomized trial of the size needed
to validate the findings at a GA of at or after 37 weeks
will ever be performed, especially since it is unlikely that
© 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 582–591.
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Table 2 Association between planned mode of delivery and adverse perinatal outcome in 5564 twins, according to gestational age at delivery













(n = 1444) OR (95% CI)
Composite adverse
perinatal outcome
2630 29 (2) 48 (4) 0.62 (0.37–1.03) 2931 23 (2) 10 (1) 2.25 (1.06–4.77)
Twin A 1315 10 (2) 20 (3) 0.51 (0.24–1.10) 1466 7 (1) 1 (0) 6.85 (0.84–55.80)
Twin B 1315 19 (3) 28 (4) 0.69 (0.38–1.26) 1465 16 (2) 9 (1) 1.74 (0.76–3.96)
Perinatal death* 2630 8 (1) 16 (1) 0.52 (0.21–1.29) 2931 9 (1) 6 (0) 1.46 (0.50–4.23)
Twin A 1315 3 (0) 7 (1) 0.44 (0.11–1.71) 1466 4 (1) 1 (0) 3.90 (0.44–34.95)
Twin B 1315 5 (1) 9 (1) 0.57 (0.19–1.72) 1465 5 (1) 5 (1) 0.97 (0.28–3.36)
Birth trauma*
Long-bone fracture* 2606 0 (0) 0 (0) — 2916 4 (1) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 0 (0) — 1455 4 (1) 0 (0) —
Other bone fracture* 2606 1 (0) 1 (0) 1.03 (0.06–16.46) 2916 0 (0) 0 (0) —
Twin A 1305 1 (0) 1 (0) 1.03 (0.06–16.50) 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 0 (0) — 1455 0 (0) 0 (0) —
Peripheral nerve injury
at 72 h of age or at
discharge*
2606 0 (0) 0 (0) — 2916 1 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 1 (0) 0 (0) —
Twin B 1301 0 (0) 0 (0) — 1455 0 (0) 0 (0) —
Subdural hematoma* 2606 0 (0) 0 (0) — 2916 0 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 0 (0) — 1455 0 (0) 0 (0) —
5-min Apgar score < 4* 2606 2 (0) 2 (0) 1.03 (0.15–7.31) 2916 5 (0) 0 (0) —
Twin A 1305 2 (0) 1 (0) 2.06 (0.19–22.80) 1461 1 (0) 0 (0) —
Twin B 1301 0 (0) 1 (0) — 1455 4 (1) 0 (0) —
Abnormal level of
consciousness*
2606 2 (0) 8 (1) 0.13 (0.02–1.05) 2916 6 (0) 5 (0) 1.95 (0.49–7.79)
Twin A 1305 0 (0) 2 (0) — 1461 2 (0) 2 (0) —
Twin B 1301 2 (0) 6 (0) 0.17 (0.02–1.42) 1455 4 (1) 3 (0) 1.29 (0.29–5.80)
Coma* 2606 1 (0) 0 (0) — 2916 0 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 1 (0) 0 (0) — 1455 0 (0) 0 (0) —
Stupor or decreased
response to pain*
2606 0 (0) 2 (0) — 2916 0 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 2 (0) — 1455 0 (0) 0 (0) —
Hyperalert, drowsy
or lethargic*
2606 1 (0) 6 (0) — 2916 6 (0) 3 (0) —
Twin A 1305 0 (0) 2 (0) — 1461 2 (0) 0 (0) —
Twin B 1301 1 (0) 4 (1) — 1455 4 (1) 3 (0) —
Neonatal seizures within
72 h of birth*
2606 2 (0) 3 (0) 0.51 (0.05–5.67) 2916 3 (0) 2 (0) —
Twin A 1305 0 (0) 1 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 2 (0) 2 (0) 0.51 (0.05–5.68) 1455 3 (0) 2 (0) —
> 2 seizures* 2606 1 (0) 1 (0) — 2916 1 (0) 2 (0) —
Twin A 1305 0 (0) 1 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 1 (0) 0 (0) — 1455 1 (0) 2 (0) —
2 seizures* 2606 1 (0) 0 (0) — 2916 0 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 1 (0) 0 (0) — 1455 0 (0) 0 (0) —
1 seizure 2606 0 (0) 2 (0) — 2916 2 (0) 0 (0) —
Twin A 1305 0 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 2 (0) — 1455 2 (0) 0 (0) —
Ventilation via
endotracheal tube
within 72 h of age*
2606 29 (2) 37 (3) 0.64 (0.31–1.32) 2916 14 (1) 3 (0) 0.65 (0.11–3.88)
Twin A 1305 6 (1) 15 (2) 0.34 (0.09–1.26) 1461 3 (0) 0 (0) —
Twin B 1301 23 (4) 22 (3) 0.82 (0.38–1.77) 1455 11 (1) 3 (0) 0.65 (0.11–3.87)
At or after 24 h* 2606 15 (1) 24 (2) — 2916 2 (0) 3 (0) —
Twin A 1305 3 (0) 9 (1) — 1461 0 (0) 0 (0) —
Twin B 1301 12 (2) 15 (2) — 1455 2 (0) 3 (0) —
Continued over.
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Table 2 Continued













(n = 1444) OR (95% CI)
Before 24 h 2606 14 (1) 13 (1) — 2916 12 (1) 0 (0) —
Twin A 1305 3 (0) 6 (1) — 1461 3 (0) 0 (0) —
Twin B 1301 11 (2) 7 (1) — 1455 9 (1) 0 (0) —
Sepsis within 72 h of
birth*
2606 2 (0) 1 (0) 2.06 (0.19–22.73) 2916 0 (0) 0 (0) —
Twin A 1305 1 (0) 0 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 1 (0) 1 (0) 1.03 (0.06–16.50) 1455 0 (0) 0 (0) —
Necrotizing
enterocolitis*
2606 2 (0) 1 (0) 2.06 (0.19–22.73) 2916 1 (0) 0 (0) —
Twin A 1305 2 (0) 1 (0) 2.06 (0.19–22.80) 1461 1 (0) 0 (0) —
Twin B 1301 0 (0) 0 (0) — 1455 0 (0) 0 (0) —
Cystic periventricular
leukomalacia*
2606 0 (0) 2 (0) — 2916 0 (0) 0 (0) —
Twin A 1305 0 (0) 1 (0) — 1461 0 (0) 0 (0) —
Twin B 1301 0 (0) 1 (0) — 1455 0 (0) 0 (0) —
Data are given as n or n (%) unless specified otherwise. *Component of composite adverse perinatal outcome. Reported odds ratios (OR)
are for dichotomized outcome, i.e. yes vs no. ORs for all infants calculated using generalized estimation equation method, which takes into
account correlation between twins. When number of events in one cell is zero, stable OR cannot be calculated. There were no infants with
spinal cord injury, basal or depressed skull fracture, subdural hematoma, meningitis, Grade-III or -IV intraventricular hemorrhage or
bronchopulmonary dysplasia in either group. CD, Cesarean delivery; VD, vaginal delivery.
women with twin pregnancy will deliver at a GA much
more advanced than ≥ 37 weeks.
The positive effect of planned CD over planned VD
shown at later GAs might be overcome by earlier planned
delivery than was advised in the TBS11. The authors of
a recently published meta-analysis recommend delivery
for monochorionic twins before 36 + 6 weeks and for
dichorionic twins before 37 + 6 weeks11.
Our analysis focused on short-term outcomes. The pro-
tective effect of VD at an earlier GA for twins seemed to
arise partly because of the lower need for assisted ventila-
tion. Children born after planned VD suffer less frequently
from respiratory problems than do those born after
planned CD, and it is very likely that this effect is more
pronounced for neonates born more prematurely. Recent
studies, performed mainly in women with a singleton
pregnancy, suggest the use of antenatal corticosteroids for
planned CD at 34–37 weeks12. We found no difference in
the proportion of women taking antenatal corticosteroids
between the two study groups. The difference in the rate
of adverse perinatal outcome between the modes of deliv-
ery might have been smaller if antenatal corticosteroids
had been given more frequently before planned CD at
34–37 weeks’ gestation. The use of antenatal cortico-
steroids was associated with a higher risk of composite
adverse perinatal outcome in both trial arms. This may
be due to confounding, as antenatal corticosteroids may
be a surrogate marker for high-risk delivery.
It is important to keep in mind that clinical deci-
sions should be made based on long-term outcomes.
The long-term outcomes of the TBS have been published
separately; no difference in the rate of adverse neurodevel-
opmental outcome was found between children born after
planned CD and those born after planned VD (5.99%
vs 5.83%; OR, 1.04 (95% CI, 0.77–1.41); P = 0.79)13.
The rate of adverse outcome after 2 years was higher
than anticipated in both study groups, probably owing
to a relatively high percentage of premature twins in
both groups13. These outcomes have, however, not been
analyzed according to GA at delivery.
Perinatal outcome alone should not influence the
decision of mode of delivery. In the TBS, no differences
were seen in short-term and serious long-term maternal
morbidity and mortality between the planned-CD and
planned-VD groups, but the study might be too small to
detect a difference in the incidence of rare, but serious,
complications1,14. CD is, based on retrospective studies,
associated with a small, but increased, incidence of
maternal complications, as compared with VD. A scarred
uterus increases the chance of morbidly adherent placenta
and uterine rupture in future pregnancies15.
In the planned-VD group, 44% of women went on
to deliver at least one twin by CD. Reassessment of
eligibility for VD at the time of labor was part of the study
protocol and, in cases of maternal or fetal complications,
CD was indicated. Therefore, the high CD rate in the
planned-VD group cannot be seen as a deviation from
protocol or crossover. In the planned-VD group, 10%
of women requested CD, which is comparable with the
7% of women who requested VD in the planned-CD
group, and which would be in the range of an acceptable
crossover rate. We emphasize that the aim of the study
was to compare the strategy of planned mode of delivery
(CD vs VD). The results of the trial and this analysis can be
used only for future counseling of women by comparing
planned mode of delivery. However, it is not possible to
predict which women will have an emergency CD during
labor despite planned VD or which will have contractions
and deliver vaginally despite planned CD.
© 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2021; 57: 582–591.
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Many more twins at the most advanced GAs, i.e. the
group with a possible benefit of planned CD, will have
been induced compared with those at lower GAs. Our
analysis was based on the intention-to-treat approach. We
did not adjust for any intervention after randomization,
such as induction of labor.
Apart from GA at delivery, none of the other examined
variables or any combination of them could identify with
acceptable precision women who would benefit from one
delivery method over the other. The presentation of the
second twin did not demonstrate potential in aiding the
decision of planned CD or planned VD in the studied
population of women. Thus, there is still a need to identify
other factors to help identify women and children who
could benefit from one planned delivery method over the
other.
In conclusion, based on a post-hoc analysis of the TBS,
we identified GA at delivery as a strong prognostic factor
for perinatal outcome, an association that was dependent
upon the planned mode of delivery. Thus, women with
a twin pregnancy and the first twin in cephalic position
should be counseled that planned VD seems to have
a favorable effect on perinatal outcome at a GA of
32–37 weeks, while, from around 37 weeks onwards, CD
might be safer for both babies, but the absolute risks
are very low and must be weighed against the increased
maternal risks associated with planned CD.
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